The University of Chicago Header Logo

Connection

Takemasa Tsuji to Interleukin-1beta

Back to Details
This is a "connection" page, showing publications Takemasa Tsuji has written about Interleukin-1beta.
Takemasa Tsuji
Connection Strength
0.027
Interleukin-1beta
  1. Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Clin Cancer Res. 2012 Oct 01; 18(19):5449-59.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.